The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Physiology and Pharmacology

• Publication date

  2004-03-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  PMID 15082872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple and reliable conflict procedure for testing anti-anxiety agents

  2004cited by this paper
• In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine).

  2003cited by this paper
• A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptors

  2002cited by this paper
• Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?

  2002cited by this paper
• Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608).

  2002cited by this paper
• Behavioral evidence supporting a differential role for spinal group I and II metabotropic glutamate receptors in inflammatory hyperalgesia in sheep.

  2002cited by this paper
• Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats.

  2002cited by this paper
• AIDA influences behavior in rats pretreated with baclofen.

  2001cited by this paper
• Glutamate receptor ligands as anxiolytics.

  2001cited by this paper
• The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration

  2001cited by this paper
• Rodent models of anxiety-like behaviors: are they predictive for compounds acting via non-benzodiazepine mechanisms?

  2001cited by this paper
• Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

  2001cited by this paper
• Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil.

  2000cited by this paper
• Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.

  2000cited by this paper
• The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity

  2000cited by this paper
• Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats.

  2000cited by this paper
• AIDA reduces glutamate release and attenuates mechanical allodynia after spinal cord injury

  2000cited by this paper
• Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms.

  1999influential reference
• Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid).

  1999cited by this paper
• 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

  1999cited by this paper
• Task-specific enhancement of short-term, but not long-term, memory by class I metabotropic glutamate receptor antagonist 1-aminoindan-1,5-dicarboxylic acid in rats.

  1999cited by this paper
• Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models.

  1999cited by this paper
• Group I metabotropic glutamate receptors: implications for brain diseases.

  1999cited by this paper
• Effects of varying the expression level of recombinant human mGlu1α receptors on the pharmacological properties of agonists and antagonists

  1999cited by this paper
• Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.

  1998cited by this paper
• Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice.

  1998cited by this paper
• Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors.

  1998cited by this paper
• Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

  1998cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997influential reference
• Design, Synthesis, and Pharmacological Characterization of (+)-2- Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties.

  1997cited by this paper
• The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats.

  1997cited by this paper
• Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist.

  1997cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997cited by this paper
• Class I mGlu receptor antagonist 1-aminoindan-1,5-dicarboxylic acid blocks contextual but not cue conditioning in rats.

  1997cited by this paper
• Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists.

  1996cited by this paper
• Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

  1996cited by this paper
• The metabotropic glutamate receptors: structure and functions.

  1995cited by this paper
• 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors.

  1995influential reference
• Use of the elevated plus maze in the search for novel anxiolytic agents.

  1995cited by this paper
• Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.

  1994influential reference
• Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain.

  1993cited by this paper
• Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction.

  1992cited by this paper
• Cellular localization of a metabotropic glutamate receptor in rat brain.

  1992cited by this paper
• Sequence and expression of a metabotropic glutamate receptor

  1991cited by this paper
• Effects of drugs on punished behavior: pre-clinical test for anxiolytics.

  1990cited by this paper
• The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system.

  1989cited by this paper
• Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine

  1989cited by this paper
• Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

  1986influential reference
• Précis of The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system

  1982cited by this paper
• Possible involvement of GABA in the central actions of benzodiazepines.

  1975cited by this paper
• Evaluation of a rapid technique for detecting minor tranquilizers.

  1971cited by this paper
• Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone

  1959cited by this paper

• Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs

  2024cites this paper
• Peripheral inflammation triggering central anxiety through the hippocampal glutamate metabolized receptor 1

  2024cites this paper
• Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease

  2022cites this paper
• Clinical investigations of compounds targeting metabotropic glutamate receptors.

  2022cites this paper
• Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.

  2021cites this paper
• Anhedonia as a basic syndrome and a target for treatment for depressive disorder

  2019cites this paper
• Anxiolytic and antidepressant effects of methanol stem bark extract of Bombax buonopozense P. Beauv. (Bombacaceae)

  2018cites this paper
• Pyrrolidine Dithiocarbamate Alleviated Anxiety in Diabetic Mice

  2017cites this paper
• Rodent Models in Psychiatric Research

  2016cites this paper
• Amygdalar activation of group I metabotropic glutamate receptors produces anti- and pro-conflict effects depending upon animal sex in a sexually dimorphic conditioned conflict-based anxiety model

  2016cites this paper
• Antagonists of Metabotropic Glutamate Receptors Prevent the Development of Audiogenic Seizures

  2015cites this paper
• DIAZEPAM LIKE EFFECTS OF HERBAL EXTRACT ACACIA TORTILIS GROWING IN KSA ON LOCOMOTOR ACTIVITY IN MICE

  2014cites this paper
• Metabotropic glutamatergic receptors and their ligands in drug addiction.

  2014cites this paper
• Activation of amygdalar metabotropic glutamate receptors modulates anxiety, and risk assessment behaviors in ovariectomized estradiol-treated female rats.

  2012cites this paper
• New perspectives in glutamate and anxiety.

  2012influential citation
• Metabotropic Receptors for Glutamate and GABA

  2012cites this paper
• Elucidating the Mechanism of Action of Pregabalin

  2012cites this paper
• Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models.

  2012cites this paper
• Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination.

  2011cites this paper
• The Four-Plate Test in Mice

  2011cites this paper
• Animal models of anxiety and anxiolytic drug action.

  2010cites this paper
• Metabotropic glutamate receptors: their therapeutic potential in anxiety.

  2010cites this paper
• Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.

  2010cites this paper
• Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists

  2010cites this paper
• Effect of the class I metabotropic glutamate receptor antagonist AIDA on certain behaviours in rats with experimental chronic hyperammonemia.

  2009cites this paper
• Differential effects of MPEP and diazepam in tests of conditioned emotional response and Pavlovian-to-instrumental transfer suggests ‘anxiolytic’ effects are mediated by different mechanisms

  2009cites this paper
• Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats.

  2009cites this paper
• Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5.

  2009cites this paper
• Behavioral effects of acute and chronic oral administration of barakol in rats.

  2009cites this paper
• Effects of mGluR5 and mGluR1 antagonists on anxiety-like behavior and learning in developing rats.

  2009cites this paper
• Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs.

  2009cites this paper
• Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders

  2008cites this paper
• Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives

  2008cites this paper
• Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.

  2008cites this paper
• Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats.

  2008cites this paper
• Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.

  2007cites this paper
• Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.

  2007cites this paper
• Die Rolle metabotroper Glutamatrezeptoren der Gruppe I beim Lernen und Gedächtnis der Ratte

  2006cites this paper
• Die Rolle metabotroper Glutamatrezeptoren der Gruppe I beim Lernen und Gedächtnis der Ratte

  2006cites this paper
• Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling.

  2006cites this paper
• The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison.

  2006cites this paper
• Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans.

  2006cites this paper
• The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles

  2005influential citation
• Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.

  2005cites this paper
• Trends in der Angsttherapie

  2005cites this paper
• Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task.

  2005cites this paper
• Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test

  2004cites this paper
• Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.

  2004cites this paper